Gary has been active in the hyperthermia sector since 1992 and received the first FDA IDE to treat AIDS patients with whole-body hyperthermia in 1995. Gary’s company received the first FDA clearance for an intraperitoneal hyperthermia device in 1999 and has been commercially operating the HIPEC Procedure. This procedure is used by surgical oncologists to treat advanced abdominal cancer and is a standard of care in over 172 prestigious hospitals, including Mass General, Cleveland Clinic, Johns Hopkins, MD Anderson, and the Mayo Clinic. Gary has invented and patented two abdominal drainage catheters which are used in surgery every day throughout the world. He also developed and patented a chemotherapy sensitizing solution and co-wrote in-vitro and in-vivo study protocols for the solution. Gary attended the University of Pittsburgh in Pittsburgh, Pennsylvania, and received a BS in Economics.